Search research articles
Contact Us
Filters
Showing results (531-540 of 569) with videos related to
Page
of 57
Sort By:
The British Journal of Dermatology
|
January 26, 2010
Immunohistochemical localization of cellular NFATc1 does not predict clinical responses to ciclosporin in subcutaneous panniculitis-like T-cell non-Hodgkin lymphoma
S Tauro, S Maccallum, M J Groves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
A Korfel, M Weller, P Martus, et al.
Intensive Care Medicine
|
February 2, 2019
The diagnostic accuracy of clinical examination for estimating cardiac index in critically ill patients: the Simple Intensive Care Studies-I
Bart Hiemstra, Geert Koster, Renske Wiersema, et al.
Scientific Reports
|
June 24, 2020
Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL
V Seitz, K Kleo, A Dröge, et al.
Clinical and Experimental Immunology
|
January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis
J M Clain, A M Hummel, J H Stone, et al.
ESC Heart Failure
|
May 31, 2026
Phenotyping patients with a low-flow, low-gradient aortic stenosis and a preserved ejection fraction undergoing TAVI
K H van Bergeijk, F Roski, C S Venema, et al.
Leukemia
|
June 27, 2008
Pathway activation patterns in diffuse large B-cell lymphomas
S Bentink, S Wessendorf, C Schwaenen, et al.
Ebiomedicine
|
April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K Hoyer, R Hablesreiter, Y Inoue, et al.
International Journal of Technology Assessment in Health Care
|
January 8, 2009
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics
Valesca P Retèl, Jolien M Bueno-de-Mesquita, Marjan J M Hummel, et al.
The American Journal of Medicine
|
July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis
Javier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Page
of 57
Search research articles
Search
Showing results (531-540 of 569) with videos related to
Sort By:
Page
of 57
The British Journal of Dermatology
|
January 26, 2010
Immunohistochemical localization of cellular NFATc1 does not predict clinical responses to ciclosporin in subcutaneous panniculitis-like T-cell non-Hodgkin lymphoma
S Tauro, S Maccallum, M J Groves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
A Korfel, M Weller, P Martus, et al.
Intensive Care Medicine
|
February 2, 2019
The diagnostic accuracy of clinical examination for estimating cardiac index in critically ill patients: the Simple Intensive Care Studies-I
Bart Hiemstra, Geert Koster, Renske Wiersema, et al.
Scientific Reports
|
June 24, 2020
Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL
V Seitz, K Kleo, A Dröge, et al.
Clinical and Experimental Immunology
|
January 12, 2017
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis
J M Clain, A M Hummel, J H Stone, et al.
ESC Heart Failure
|
May 31, 2026
Phenotyping patients with a low-flow, low-gradient aortic stenosis and a preserved ejection fraction undergoing TAVI
K H van Bergeijk, F Roski, C S Venema, et al.
Leukemia
|
June 27, 2008
Pathway activation patterns in diffuse large B-cell lymphomas
S Bentink, S Wessendorf, C Schwaenen, et al.
Ebiomedicine
|
April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K Hoyer, R Hablesreiter, Y Inoue, et al.
International Journal of Technology Assessment in Health Care
|
January 8, 2009
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics
Valesca P Retèl, Jolien M Bueno-de-Mesquita, Marjan J M Hummel, et al.
The American Journal of Medicine
|
July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis
Javier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Page
of 57